Related Experiment Video
Updated: May 23, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
Published on: March 6, 2018
Diethylstilboestrol--a long-term legacy
1School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Abstract:
Diethylstilboestrol (DES) is an endocrine disrupter which causes cancer in rodents. It was prescribed in large amounts to treat women with gynaecological problems; some of the daughters of these women subsequently developed a rare cancer (vaginal clear cell adenocarcinoma) while genital abnormalities were found in some of the sons. It was used for decades in livestock feed and this may have contaminated the food chain leading to the exposure of the more general population. DES appears to cause epigenetic effects in animals and there is some evidence that this also occurs in man. The mechanisms of carcinogenesis are complex and the effects are difficult to prove due to the background of dietary and environmental phyto- and xenooestrogens. It has been suggested that, like other endocrine disrupters, DES may have acted as an obesogen in the human population.
Insights
Diethylstilboestrol (DES) is an endocrine-disrupting chemical linked to cancers and reproductive abnormalities in humans. Its widespread use in medicine and agriculture raises concerns about population-wide exposure and potential epigenetic effects.
Area of Science:
- Endocrinology
- Environmental Health
- Toxicology
Background:
- Diethylstilboestrol (DES) is a synthetic estrogen with endocrine-disrupting properties.
- DES was widely prescribed for gynecological issues and used in livestock, leading to potential human exposure.
- Observed health issues in DES-exposed offspring include rare cancers and genital abnormalities.
Purpose of the Study:
- To review the evidence on Diethylstilboestrol (DES) as an endocrine disruptor.
- To explore the mechanisms of DES-induced carcinogenesis and epigenetic effects.
- To assess the potential role of DES as an obesogen in human populations.
Main Methods:
- Literature review of epidemiological studies and animal research on DES.
- Analysis of documented health outcomes in individuals exposed to DES.
- Evaluation of proposed mechanisms of endocrine disruption and carcinogenesis.
Main Results:
- DES exposure is associated with an increased risk of specific cancers, such as clear cell adenocarcinoma.
- Evidence suggests DES can induce epigenetic modifications in exposed individuals.
- Potential links between DES exposure and increased obesity rates are being investigated.
Conclusions:
- Diethylstilboestrol (DES) poses significant health risks due to its endocrine-disrupting and carcinogenic potential.
- Epigenetic effects and obesogenic properties warrant further investigation.
- Minimizing exposure to endocrine disruptors like DES is crucial for public health.
More Related Videos
08:58Using Caenorhabditis elegans for Studying Trans- and Multi-Generational Effects of Toxicants
Published on: July 29, 2019
08:28Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays
Published on: April 26, 2018
Related Concept Videos
Teratogenicity
Toxicity Testing in Animals
Intrauterine Drug Delivery Systems
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Drug Regulation
Ethics in Research